HOMRE LIMITED schedules board meeting for Q4FY26
HOMRE LIMITED has scheduled a board meeting for May 20, 2026, to discuss Q4FY26 results under Regulation 29.

*this image is generated using AI for illustrative purposes only.
HOMRE LIMITED has announced that its board meeting is scheduled to take place on May 20, 2026. The primary agenda for this meeting is the consideration and approval of the financial results for the fourth quarter of the fiscal year 2026 (Q4FY26). The company has intimated this to the stock exchanges in compliance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Meeting Details
The board meeting will focus on reviewing the company's performance during the quarter ending March 31, 2026. The outcome of this meeting, particularly the approval of the financial results, will be disclosed to the exchanges post-meeting.
| Event | Date |
|---|---|
| Board Meeting | May 20, 2026 |
| Quarter Under Review | Q4FY26 |
Regulatory Compliance
The intimation regarding the board meeting was issued to ensure adherence to the regulatory framework governing periodic disclosures. The company stated that the meeting is convened strictly under the provisions of Regulation 29.
Historical Stock Returns for HOMRE
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.67% | -10.64% | +55.56% | +20.49% | +415.79% | +1,447.37% |
What revenue and profit growth trajectory is HOMRE LIMITED expected to report for Q4 FY26 compared to previous quarters?
Will HOMRE LIMITED's board consider announcing a dividend or any capital allocation decisions alongside the Q4 FY26 results?
How has HOMRE LIMITED's stock performance trended ahead of the May 20 board meeting, and what are analyst expectations for the full-year FY26 results?


































